[
  {
    "ts": "2025-12-23T11:30:23+00:00",
    "headline": "Strategists are bullish on healthcare in 2026: 3 top stock picks",
    "summary": "Catalyst Funds chief investment officer and senior portfolio manager David Miller and Marketgauge.com chief strategist Michele Schneider join Morning Brief host Julie Hyman to share some of their top stock picks in the healthcare (XLV) sector. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.",
    "url": "https://finance.yahoo.com/video/strategists-bullish-healthcare-2026-3-113023169.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "51597f2b-c29f-3015-a856-9e2f08030784",
      "content": {
        "id": "51597f2b-c29f-3015-a856-9e2f08030784",
        "contentType": "VIDEO",
        "title": "Strategists are bullish on healthcare in 2026: 3 top stock picks",
        "description": "<p>Catalyst Funds chief investment officer and senior portfolio manager David Miller and Marketgauge.com chief strategist Michele Schneider join Morning Brief host <a data-i13n=\"cpos:1;pos:1\" href=\"https://finance.yahoo.com/author/julie-hyman/\">Julie Hyman</a> to share some of their top stock picks in the healthcare (<a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/quote/XLV\">XLV</a>) sector.</p>\n<p>To watch more expert insights and analysis on the latest market action, check out more <a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/videos/series/morning-brief/\">Morning Brief</a>.</p>",
        "summary": "Catalyst Funds chief investment officer and senior portfolio manager David Miller and Marketgauge.com chief strategist Michele Schneider join Morning Brief host Julie Hyman to share some of their top stock picks in the healthcare (XLV) sector. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.",
        "pubDate": "2025-12-23T11:30:23Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-12/3d6b9c60-df47-11f0-93f0-72289b73da5a",
          "originalWidth": 4200,
          "originalHeight": 2365,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bDMZt1jtf54JUROfgvlyow--~B/aD0yMzY1O3c9NDIwMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-12/3d6b9c60-df47-11f0-93f0-72289b73da5a.cf.webp",
              "width": 4200,
              "height": 2365,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/r3.x5TXRPXl0PPaEF1nPMQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-12/3d6b9c60-df47-11f0-93f0-72289b73da5a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/strategists-bullish-healthcare-2026-3-113023169.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/strategists-bullish-healthcare-2026-3-113023169.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MEDP"
            },
            {
              "symbol": "TMDX"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "XLV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T11:37:55+00:00",
    "headline": "3 Stocks Estimated To Be Trading Below Fair Value By Up To 46%",
    "summary": "As the U.S. stock market continues its upward trajectory, with major indices like the S&P 500 and Dow Jones Industrial Average nearing record highs, investors are increasingly on the lookout for opportunities that may be flying under the radar. In such a climate, identifying stocks that are estimated to be trading below their fair value can offer potential pathways to capitalize on market movements, especially when tech shares lead the charge and precious metals hit fresh records.",
    "url": "https://finance.yahoo.com/news/3-stocks-estimated-trading-below-113755829.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "fe028778-39c7-37da-ac77-f90f1de60f08",
      "content": {
        "id": "fe028778-39c7-37da-ac77-f90f1de60f08",
        "contentType": "STORY",
        "title": "3 Stocks Estimated To Be Trading Below Fair Value By Up To 46%",
        "description": "",
        "summary": "As the U.S. stock market continues its upward trajectory, with major indices like the S&P 500 and Dow Jones Industrial Average nearing record highs, investors are increasingly on the lookout for opportunities that may be flying under the radar. In such a climate, identifying stocks that are estimated to be trading below their fair value can offer potential pathways to capitalize on market movements, especially when tech shares lead the charge and precious metals hit fresh records.",
        "pubDate": "2025-12-23T11:37:55Z",
        "displayTime": "2025-12-23T11:37:55Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/a192a90509b207df974cc973e0c18172",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zcvqJ.rdXZ_29KqIsTLT6w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/a192a90509b207df974cc973e0c18172.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DcBS7NpZ60GKZMC5QwFweA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/a192a90509b207df974cc973e0c18172.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/3-stocks-estimated-trading-below-113755829.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-stocks-estimated-trading-below-113755829.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CWBC"
            },
            {
              "symbol": "FLY"
            },
            {
              "symbol": "KEY"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "QXO"
            },
            {
              "symbol": "UMBF"
            },
            {
              "symbol": "SRAD"
            },
            {
              "symbol": "SMA"
            },
            {
              "symbol": "WGS"
            },
            {
              "symbol": "COLB"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T12:42:20+00:00",
    "headline": "2026 Rate Cuts Coming as Inflation Drops: 5 Quality Dividend Stocks to Buy Now",
    "summary": "Growth and income investors can buy these five top dividend stocks now, tomorrow, next week, or next year and hold for the long term.",
    "url": "https://247wallst.com/investing/2025/12/23/2026-rate-cuts-coming-as-inflation-drops-5-quality-dividend-stocks-to-buy-now/",
    "source": "24/7 Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "ae54b8cb-e6cb-3b02-8df5-c8c7ae9d2fd9",
      "content": {
        "id": "ae54b8cb-e6cb-3b02-8df5-c8c7ae9d2fd9",
        "contentType": "STORY",
        "title": "2026 Rate Cuts Coming as Inflation Drops: 5 Quality Dividend Stocks to Buy Now",
        "description": "",
        "summary": "Growth and income investors can buy these five top dividend stocks now, tomorrow, next week, or next year and hold for the long term.",
        "pubDate": "2025-12-23T12:42:20Z",
        "displayTime": "2025-12-23T12:42:20Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/24_7_wall_st__718/0bbdbea1d8f9697a81be5c106e781bbf",
          "originalWidth": 1500,
          "originalHeight": 633,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/paTklAEV5Op0jmdTtXAUzQ--~B/aD02MzM7dz0xNTAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/24_7_wall_st__718/0bbdbea1d8f9697a81be5c106e781bbf.cf.webp",
              "width": 1500,
              "height": 633,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iuzESHkBcw0o9f_jnkSH8g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/24_7_wall_st__718/0bbdbea1d8f9697a81be5c106e781bbf.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "24/7 Wall St.",
          "url": "https://247wallst.com/"
        },
        "canonicalUrl": {
          "url": "https://247wallst.com/investing/2025/12/23/2026-rate-cuts-coming-as-inflation-drops-5-quality-dividend-stocks-to-buy-now/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2026-rate-cuts-coming-inflation-124220875.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GS"
            },
            {
              "symbol": "XOM"
            },
            {
              "symbol": "MCD"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "LMT"
            },
            {
              "symbol": "MDT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T13:48:00+00:00",
    "headline": "5 Big Drug Stocks That May Continue to Outperform in 2026",
    "summary": "Five big drugmakers, including LLY and JNJ, are riding innovation, dealmaking and pipeline momentum that could help them keep outperforming in 2026.",
    "url": "https://finance.yahoo.com/news/5-big-drug-stocks-may-134800671.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "365f8e8a-12dd-3afc-b85f-9a89dded47c3",
      "content": {
        "id": "365f8e8a-12dd-3afc-b85f-9a89dded47c3",
        "contentType": "STORY",
        "title": "5 Big Drug Stocks That May Continue to Outperform in 2026",
        "description": "",
        "summary": "Five big drugmakers, including LLY and JNJ, are riding innovation, dealmaking and pipeline momentum that could help them keep outperforming in 2026.",
        "pubDate": "2025-12-23T13:48:00Z",
        "displayTime": "2025-12-23T13:48:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/4658663242c3a61dee3fef55a1bf4887",
          "originalWidth": 620,
          "originalHeight": 413,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rbSgl25Zi2GiiDMk0hXrSg--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4658663242c3a61dee3fef55a1bf4887.cf.webp",
              "width": 620,
              "height": 413,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NAknAcj0fz57CxpyeoYG3A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4658663242c3a61dee3fef55a1bf4887.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/5-big-drug-stocks-may-134800671.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/5-big-drug-stocks-may-134800671.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T09:32:04+00:00",
    "headline": "Beyond Botox: AbbVie’s push for broader gains in neurotoxin R&D",
    "summary": "The large pharma is advancing two next-generation neurotoxins in both the therapeutic and aesthetic spaces.",
    "url": "https://www.pharmavoice.com/news/botox-abbvie-neurotoxin-parkinsons-drug-pharma/808564/",
    "source": "Pharma Voice",
    "provider": "yfinance",
    "raw": {
      "id": "86579a38-ae0c-38e7-a27f-db6063b585aa",
      "content": {
        "id": "86579a38-ae0c-38e7-a27f-db6063b585aa",
        "contentType": "STORY",
        "title": "Beyond Botox: AbbVie’s push for broader gains in neurotoxin R&D",
        "description": "",
        "summary": "The large pharma is advancing two next-generation neurotoxins in both the therapeutic and aesthetic spaces.",
        "pubDate": "2025-12-23T09:32:04Z",
        "displayTime": "2025-12-23T09:32:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharma_voice_330/851fb4e7ea2ff8b4c9e496b74f98f8d5",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "AbbVie logo on the facade of its headquarters in San Francisco, Calif., on July 31, 2021. ",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yMmzeILKgPa6T4PzgeTXmQ--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharma_voice_330/851fb4e7ea2ff8b4c9e496b74f98f8d5.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/s_D21iV0hxixt0w8DdFvgA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharma_voice_330/851fb4e7ea2ff8b4c9e496b74f98f8d5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharma Voice",
          "url": "https://www.pharmavoice.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmavoice.com/news/botox-abbvie-neurotoxin-parkinsons-drug-pharma/808564/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/beyond-botox-abbvie-push-broader-093204170.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T15:51:00+00:00",
    "headline": "ABBV vs. AZN: Which Pharma Stock is the Better Investment Now?",
    "summary": "AbbVie and AstraZeneca both bring blockbuster drugs, deep pipelines and risks, but their growth paths, pressures and priorities now sharply diverge.",
    "url": "https://finance.yahoo.com/news/abbv-vs-azn-pharma-stock-155100815.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "51c22cfd-2655-30f7-8e08-df4b73fd6e3a",
      "content": {
        "id": "51c22cfd-2655-30f7-8e08-df4b73fd6e3a",
        "contentType": "STORY",
        "title": "ABBV vs. AZN: Which Pharma Stock is the Better Investment Now?",
        "description": "",
        "summary": "AbbVie and AstraZeneca both bring blockbuster drugs, deep pipelines and risks, but their growth paths, pressures and priorities now sharply diverge.",
        "pubDate": "2025-12-23T15:51:00Z",
        "displayTime": "2025-12-23T15:51:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TNBAnrhWOnvvvNSvMEIuFg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rP7ZEHNft_Sb_FB9M.3i3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbv-vs-azn-pharma-stock-155100815.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbv-vs-azn-pharma-stock-155100815.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "AZN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]